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Protein Z is a vitamin K-dependent plasma
glycoprotein that presents structural similarities
with some coagulation factors such as factors VII,
IX, X and protein C [1].
The physiological function of protein Z has
been uncertain for many years until Han et al.
demonstrated that protein Z plays an important
role in inhibiting coagulation as it serves as
cofactor for the inactivation of activated factor
X by forming a complex with the plasma protein
Z-dependent protease inhibitor [2]. Over the last
years, some studies have reported a role for
protein Z plasma levels in prothrombotic condi-
tions, such as ischemic stroke and acute coronary
syndromes [3—5].
Protein Z is synthesised mainly by the liver as
shown by its cloning from that tissue [6]; never-
theless, protein Z has been found in endothelial
cells [7] and a recent communication suggested
that it might be synthesised also by endothelial
cells (Vasse et al., 2003, personal communication).
Therefore, we performed this study in order to
discover whether protein Z is produced by human
umbilical vein endothelial cells (HUVEC), and if this
production is affected by the inflammatory process
and by heparin.
HUVEC were purchased and grown in endothelial
growth medium-2 with BulletKit (Cambrex Bio
Science, Walkersville, MA, USA) at 37 8C with 5%
CO2. After 24 h of initial plating the medium was
replaced every day with fresh culture medium and
supplemented with growth factors. Furthermore,
the cultures were daily examined for growth and
monolayer adhesion by using an optical micro-
scope. At the second passage, HUVEC were de-
tached using trypsin for 5 min at 37 8C, shared into
25 flasks and grown up to 90% confluence (approx-
imately 62,500 cells in each flask). Before
performing the experiment, the medium was
changed in a nutrient mixture without fetal bovine
serum and heparin for 12 h.0049-3848/$ - see front matter D 2005 Elsevier Ltd. All rights reserv
doi:10.1016/j.thromres.2005.10.005No stimulation was performed in 10 flasks,
whereas the others were activated for 18 h with
tumour necrosis factor-a (TNF-a) 25 ng/ml, for 18
h with heparin 1 U/ml and, for the same period,
with both. Among the 10 non-stimulated flasks,
cells were immediately detached in 5 of them,
while in the remaining 5 cells were collected after
18 h. The supernatant was obtained, cells were
detached and lysed by sonication, and protein Z
levels were quantified in the supernatant and in the
cellular lysate by using an ELISA assay, with a
detection limit of 1.03 ng/ml (Diagnostica Stago,
Asnieres, France). In addition, we measured in the
supernatant tissue factor (TF) and tissue factor
pathway inhibitor-free (TFPI-free) by ELISA assays
(American Diagnostica Inc., Greenwich, USA; Diag-
nostica Stago, Asnieres, France, respectively) in
order to verify cells’ response in relation to the
stimulation by TNF-a and heparin.
Our experiment showed no detectable values of
protein Z in the supernatant both with and with-
out stimulus. Conversely, as expected, the release
of TF and TFPI-free was significantly influenced
by TNF-a (paired t-test: p b0.001) and heparin
addition (paired t-test: p b0.05), respectively
(Table 1).
To date, this study shows that human endothe-
lial cells are not a source of protein Z. In addition,
it demonstrates that heparin administration does
not influence the release of protein Z by endothe-
lial cells, as happens with TFPI, one of the major
haemostatic regulatory molecule synthesised by
endothelium.
Actually, the wide distribution of protein Z
plasma levels in normal population has suggested
a possible regulatory role of inflammatory cyto-
kines on protein Z biosynthesis. In 1999, Undar at
al. demonstrated that, in patients with haemato-
logical malignancies, an inverse correlation be-
tween protein Z and interleukin-6 (IL-6) plasma
levels was present, so suggesting a regulation of
protein Z synthesis by IL-6 [8]. On the other hand,
in 2002, Vasse et al. observed that protein Z
biosynthesis by hepatic cells was only weaklyARTICLE IN PRESS
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Table 1 Effect of tumour necrosis factor-a and heparin on protein Z, tissue factor pathway inhibitor-free and
tissue factor biosynthesis by human umbilical vein endothelial cells
No stimulus
(T =0)
No stimulus
(T =18 h)
TNF-a 25 ng/ml
(T =18 h)
Heparin 1 U/ml
(T =18 h)
TNF-a 25 ng/ml+heparin
1 U/ml (T =18 h)
Protein Z (ng/ml) N.D. N.D. N.D. N.D. N.D.
TFPI-free (ng/ml) 28.0F0.9 71.1F4.8 72.5F3.4 102.1F7.1* 86.3F0.6*
TF (pg/ml) 69.3F0.9 84.4F0.7 162.4F2.5** 52.7F2.3** 116.9F8.1**
N.D.=not detectable, TNF=tumour necrosis factor, TFPI=tissue factor pathway inhibitor, TF=tissue factor, HUVEC=human
umbilical vein endothelial cells.
*p b0.05, **p b0.001; reference group: no stimulus (T =18 h).
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interleukin-1, TNF-a, IL-6 and oncostatin M [9].
A possible limitation of the study is the lack of
vitamin K in the media for this experiments.
Presently, we did not add vitamin K since a previous
paper by Fair et al. [10] showed that vitamin K was
not essential for the synthesis of another vitamin K-
dependent protein, protein S, even though vitamin
K addition increased its secretion by endothelial
cells.
In conclusion, our experimental investigation
shows that protein Z is not synthesised by endo-
thelial cells, even after stimulation with heparin
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